Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., Cooper, C.·2003·Arthritis & Rheumatism

DOI 10.1002/art.11283

Cited by (556)

Items 201–300 of 556

Prevalence of Evaluation and Treatment of Glucocorticoid-Induced Osteoporosis in Men
Laura M. Cruse, Joanne Valeriano, Frank B. Vasey, John D. Carter · 2006 · JCR Journal of Clinical Rheumatology
Systemic lupus erythematosus, bone health, and osteoporosis
Cuoghi Edens, Angela Byun Robinson · 2015 · Current Opinion in Endocrinology Diabetes and Obesity
Clinical role of bisphosphonate therapy
Ignac Fogelman, Hampson · 2012 · International Journal of Women s Health
Mapping the prescriptiome to fractures in men—a national analysis of prescription history and fracture risk
Bo Abrahamsen, Kim Brixen · 2008 · Osteoporosis International
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration
Tomonori Kobayakawa, Akiko Miyazaki, Yasuhide Kanayama, Yuji Hirano, Jun A. Takahashi, Takako Suzuki, Yukio Nakamura · 2022 · Modern Rheumatology
How to prevent glucocorticoid-induced osteoporosis
Robin K. Dore · 2010 · Cleveland Clinic Journal of Medicine
Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
Richard Eastell, Peiqi Chen, Kenneth G. Saag, Alan Burshell, Mayme Wong, Margaret R. Warner, John Henry Krege · 2010 · Bone
Effectiveness of Teriparatide in Postmenopausal Women with Osteoporosis and Glucocorticoid Use: 3-Year Results from the EFOS Study
Dimitrios Karras, Ivaylo Stoykov, Willem Frederik Lems, Bente Lomholt Langdahl, Östen Ljunggren, Annabel Barrett, James Bernard Walsh, Astrid Fahrleitner‐Pammer, Gérald Rajzbaum, Franz Josef Jakob et al. · 2012 · The Journal of Rheumatology
Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis
Christos V. Chalitsios, Dominick E. Shaw, Tricia M. McKeever · 2021 · Respiratory Medicine
A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration
Janaina Santos Badin Carvas, Rosa Maria Rodrigues Pereira, Valéria F. Caparbo, Priscila Fuller, Celey Aparecida Silveira, Luiz Antônio Pugliesi Alves de Lima, Eloísa Bonfá, Suzana Beatriz Veríssimo de Mello · 2009 · Osteoporosis International
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity
Giulia Bellini, Marco Torella, Iolanda Manzo, Chiara Tortora, Livio Luongo, Francesca Punzo, Nicola Colacurci, Brúno Nobili, Sabatino Maione, Francesca Rossi · 2016 · Pharmacological Research
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
Christian Roux, David M. Reid, J. P. Devogelaer, Kenneth G. Saag, Chak Sing Lau, J.-Y. Reginster, P. Papanastasiou, Christina M. Bucci-Rechtweg, G. Su, Phillip N. Sambrook · 2011 · Osteoporosis International
The risk of osteoporosis in patients with asthma
Indumathi Kumarathas, Torben Harsløf, Charlotte Uggerhøj Andersen, Bente Lomholt Langdahl, Ole Hilberg, Leif Hilding Bjermer, Anders Løkke · 2020 · European Clinical Respiratory Journal
Glucocorticoid-Induced Changes in the Geometry of Osteoclast Resorption Cavities Affect Trabecular Bone Stiffness
Jef Vanderoost, Kent Søe, Ditte Marie Horslev Merrild, Jean‐Marie Delaissé, Harry van Lenthe · 2012 · Calcified Tissue International
Treatment of glucocorticoid‐induced low bone mineral density in children: a systematic review
Arundathi Jayasena, Navoda Atapattu, Sarath Lekamwasam · 2015 · International Journal of Rheumatic Diseases
Drugs that may harm bone: Mitigating the risk
Faye N. Hant, Marcy B. Bolster · 2016 · Cleveland Clinic Journal of Medicine
Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
Yasuaki Hirooka, Yuji Nozaki, Asuka Inoue, Jinhai Li, Toshihiko Shiga, Kazuya Kishimoto, Masafumi Sugiyama, Koji Kinoshita, Masanori Funauchi, Itaru Matsumura · 2020 · Bone Reports
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial
Chi Chiu Mok, M.K.H. Tong, Chi Hung To, Yui-Pong Siu, K. M. · 2007 · Osteoporosis International
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Cyrus C. Cooper, Thomas Bardin, Maria Luisa Brandi, P. Cacoub, John N Caminis, Roberto Civitelli, Maurizio Cutolo, Willard H. Dere, Jean‐Pierre Devogelaer, Adolfo Díez‐Pérez et al. · 2016 · Aging Clinical and Experimental Research
Managing osteoporosis: Challenges and strategies
Edward Michael Lewiecki · 2009 · Cleveland Clinic Journal of Medicine
Prevention of glucocorticoid induced bone changes with beta-ecdysone
Dai, Weiwei, Jiang, Li, Lay, Yu-An Evan, Chen, Haiyan, Jin, Guoqin, Zhang, Hongliang, Kot, Alexander, Ritchie, Robert O., Lane, Nancy E., Yao, Wei · 2015 · Bone
Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis
Dam Kim, Soo‐Kyung Cho, Byeongju Park, Eun Jin Jang, Sang‐Cheol Bae, Yoon‐Kyoung Sung · 2018 · The Journal of Rheumatology
Corticosteroids and Their Use in Respiratory Disorders
Ibrahim Ahmed Janahi, Abdul Rehman, Noor Ul-Ain Baloch · 2018 · InTech eBooks
Ptychographic X-ray CT characterization of the osteocyte lacuno-canalicular network in a male rat's glucocorticoid induced osteoporosis model
Antonia Ciani, Hechmi Toumi, Stéphane Pallu, Esther H. R. Tsai, Ana Díaz, Manuel Guizar‐Sicairos, Mirko Holler, Éric Lespessailles, Cameron M. Kewish · 2018 · Bone Reports
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
Juliet Elizabeth Compston, David M. Reid, J. Boisdron, Maria Luisa Brandi, Nansa Burlet, David L. Cahall, Pierre Dominique Delmas, Willard H. Dere, J.-P. Devogelaer, Lorraine A. Fitzpatrick et al. · 2008 · Osteoporosis International
Prevention and treatment of glucocorticoid-induced osteoporosis in 2005
Philippe Orcel · 2005 · Joint Bone Spine
Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study
Núria Guañabens, José Manuel Olmos, José L. Hernández, Dacia Cerdá, Cristina Hidalgo, Joaquín Martínez‐López, Luis R. Arboleya, Francisco Javier Aguilar del Rey, Sílvia Martínez Pardo, Inmaculada Ros Vilamajó et al. · 2021 · Osteoporosis International
Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients
Steven Wai Ing, Loraine T. Sinnott, Sirisha Donepudi, Elizabeth A. Davies, Ronald P. Pelletier, Nancy E. Lane · 2010 · Clinical Transplantation
Optimum management of glucocorticoid-treated patients
Subbulaxmi Trikudanathan, Graham T. McMahon · 2008 · Nature Clinical Practice Endocrinology &#38 Metabolism
Densitometry in Glucocorticoid-Induced Osteoporosis
Michael J. Maricic, Oscar S. Gluck · 2004 · Journal of Clinical Densitometry
Prevention and treatment of glucocorticoid-induced osteoporosis
Jeffrey R. Curtis, Kenneth G. Saag · 2007 · Current Osteoporosis Reports
Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing’s Syndrome
Barbara Stachowska, Jowita Halupczok-Żyła, Justyna Kuliczkowska-Płaksej, Joanna Syrycka, Marek Bolanowski · 2021 · Frontiers in Endocrinology
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low‐Dose Glucocorticoids and Prevention by Anti‐Osteoporosis Medications
Giovanni Adami, Angelo Fassio, Maurizio Rossini, Camilla Benini, Francesca Pistillo, Ombretta Viapiana, Davide Bertelle, Davide Gatti · 2023 · Arthritis & Rheumatology
RETRACTED ARTICLE: Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis – usefulness of alendronate and risedronate
Jun Iwamoto, Tsuyoshi Takeda, Yoshihiro Satō · 2007 · Expert Opinion on Pharmacotherapy · Retracted
Glucocorticoids and the risk of osteoporosis
Liron Caplan, Kenneth G. Saag · 2008 · Expert Opinion on Drug Safety
Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation
Takaaki Noguchi, Kosuke Ebina, Makoto Hirao, T. Morimoto, K. Koizumi, Kazuma Kitaguchi, Hozo Matsuoka, T. Iwahashi, Hideki Yoshikawa · 2016 · Osteoporosis International
Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality
L. Xi, Paolino De Falco, Ettore Barbieri, Angelo Karunaratne, Liz Bentley, Christopher T. Esapa, Nicholas J. Terrill, S.D.M. Brown, Roger Cox, Graham Roy Davis et al. · 2018 · Acta Biomaterialia
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy
Adam D. Taylor, Kenneth G. Saag · 2019 · Core evidence
Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy
Guanwu Li, Shixin Chang, Jingzheng Fan, Yanan Tian, Zheng Xu, Yanming He · 2012 · Bone
Prevention and management of co-morbidities in SLE
Tanmayee Bichile, Michelle Petri · 2014 · La Presse Médicale
Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020)
Rosa Maria Rodrigues Pereira, Mariana Ortega Perez, Ana Patrícia de Paula, Caio Moreira, Charlles Heldan de Moura Castro, Cristiano A. F. Zerbini, Diogo Souza Domiciano, Elaine de Azevedo, Laura Maria Carvalho de Mendonça, Márcia Midori Shinzato et al. · 2021 · Archives of Osteoporosis
Recommendations by the Spanish Society of Rheumatology on Osteoporosis
Antonio Naranjo, Petra Díaz del Campo Fontecha, María Pilar Aguado Acín, Luis Marcelino Arboleya Rodríguez, E. Casado, Santos Castañeda, Jordi Fiter Aresté, Laia Gifre, Carmen Gómez Vaquero, Gloria Candelas Rodríguez et al. · 2019 · Reumatología Clínica (English Edition)
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease
Stefano Palomba, Francesco Orio, Francesco Manguso, Angela Immacolata Falbo, Tiziana Russo, Achille Tolino, Libuse Tauchmanovà, Annamaria Anita Livia Colao, Patrizia Doldo, Pasquale Mastrantonio et al. · 2005 · Osteoporosis International
6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis
Alessandra Soares Schanoski, Vanesa Goméz-Piña, Carlos del Fresno, Alexandro Rodríguez-Rojas, Felipe García, Alberto Glaría, Miriam Sánchez, María Teresa Vallejo‐Cremades, Rosa Baos, Pablo Fuentes‐Prior et al. · 2007 · Journal of Leukocyte Biology
Glucocorticoid-Induced Osteoporosis
Robert A. Adler, Jeffrey R. Curtis, Robert S. Weinstein, Kenneth G. Saag · 2008 · Elsevier eBooks
Risk factors associated with incident fractures in Japanese men with rheumatoid arthritis: a prospective observational cohort study
Takefumi Furuya, Shigeru Kotake, Eisuke Inoue, Yuki Nanke, Toru Yago, Masako Hara, Taisuke Tomatsu, Naoyuki Kamatani, Hisashi Yamanaka · 2008 · Journal of Bone and Mineral Metabolism
Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update
Osvaldo Daniel Messina, Maritza Vidal, Jorge A Morales Torres, Luis Fernando Vidal, Constanza Arguissain, Rosa Maria Rodrigues Pereira, Patricia Clark, Sonia Cerdas Pérez, Claudia Campusano, Marise Lazaretti‐Castro et al. · 2022 · Aging Clinical and Experimental Research
WNT16 overexpression partly protects against glucocorticoid-induced bone loss
Claes Ohlsson, Karin H. Nilsson, Petra Henning, Jianyao Wu, Karin L. Gustafsson, Matti H. POUTANEN, Ulf H. Lerner, Sofia Movérare‐Skrtic · 2018 · American Journal of Physiology-Endocrinology and Metabolism
Variable Deficits of Bone Mineral Despite Chronic Glucocorticoid Therapy in Pediatric Patients with Inflammatory Diseases: Α Glaser Pediatric Research Network Study
Emily von Scheven, Catherine M. Gordon, David Wypij, Marcia Stanley Wertz, Kerry T. Gallagher, Laura K. Bachrach · 2006 · Journal of Pediatric Endocrinology and Metabolism
PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis
Yifeng Shi, Qian Tang, Sunren Sheng, Hongyi Jiang, Chen Jin, Chenjie Zhou, Chenglong Xie, Lin Zheng, Di Zhang, Hui Xu et al. · 2025 · Advanced Science
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders
Athol Umfrey Wells, Elyse E. Lower, Robert P. Baughman, Daniel A. Culver, Marc A. Judson, Catherine A. Bonham, Alicia K. Gerke, Jan C. Grutters, Chris Knoet, Filippo Martone et al. · 2025 · The Lancet Respiratory Medicine
Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy
Onorina Berardicurti, Piero Ruscitti, Viktoriya Pavlych, Alessandro Conforti, Roberto Giacomelli, Paola Cipriani · 2020 · Expert Review of Clinical Pharmacology
Hospitalisations, admission costs and re‐fracture risk related to osteoporosis in Western Australia are substantial: a 10‐year review
Andrew M. Briggs, Wenxing Sun, Laura Miller, Elizabeth A. Geelhoed, Anna Huska, Charles Anoopkumar Inderjeeth · 2015 · Australian and New Zealand Journal of Public Health
Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis?
Juliet Elizabeth Compston · 2011 · Clinical Endocrinology
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis
Juliet Elizabeth Compston · 2023 · European Journal of Endocrinology
Is long-term glucocorticoid therapy associated with a high prevalence of asymptomatic vertebral fractures?
Robert S. Weinstein · 2007 · Nature Clinical Practice Endocrinology &#38 Metabolism
Bone Health Should Be an Important Concern in the Care of Patients Affected by 21 Hydroxylase Deficiency
Anne Bachelot, Zeina Chakhtoura, Dinane Samara‐Boustani, Jérôme Dulon, Philippe A. Touraine, Michel Polak · 2010 · International Journal of Pediatric Endocrinology
Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study
B-M Nyhäll-Wåhlin, Sofia Ajeganova, Ingemar F. Petersson, MLE Andersson · 2019 · Scandinavian Journal of Rheumatology
A systematic review and meta‐analysis on the incidence of osteoporosis and fractures after liver transplant
Wen Hui Lim, Cheng Han Ng, Zachariah Gene Wing Ow, Owen Tsung Wen Ho, Phoebe Wen Lin Tay, Keng Lin Wong, Eunice Xiang Xuan Tan, Si Ying Tang, Claire Min‐Li Teo, Mark Dhinesh Muthiah · 2021 · Transplant International
Recommendations for the Registration of Agents to be Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Updated Recommendations from the Group for the Respect of Ethics and Excellence in Science
Eric C. Abadie, Jean-Pierre Devogealer, Johann Diederich Ringe, Dominique J. Ethgen, G Bouvenot, Gottfried Kreutz, Andrea Laslop, John J. Orloff, Philippe M. Vanderauwera, Pierre Dominique Delmas et al. · 2005 · Seminars in Arthritis and Rheumatism
Guías 2012 para el diagnóstico, la prevención y el tratamiento de la osteoporosis
León Schurman, A. Bagur, Haraldo Claus-Hermberg, Osvaldo Daniel Messina, Armando Luis Negri, Ariel Sánchez, Claudio Daniel González, María Diehl, Paula Rey, Julieta Gamba et al. · 2013 · Actualizaciones en osteología
Bisphosphonates and glucocorticoid-induced osteoporosis: cons
Willem Frederik Lems, Kenneth G. Saag · 2015 · Endocrine
Osteoporosis in men
Nichole L Korpi-Steiner, Denise M. Milhorn, Catherine A. Hammett‐Stabler · 2014 · Clinical Biochemistry
Bone and glucocorticoids
Karine Briot · 2018 · Annales d Endocrinologie
Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines
Tae-Han Lee, Yeo‐Jin Song, Hyoungyoung Kim, Yoon‐Kyoung Sung, Soo‐Kyung Cho · 2020 · Journal of Bone Metabolism
Densitometric Threshold and Vertebral Fractures in Heart Transplant Patients
Luca Dalle Carbonare, Mirko Zanatta, V. Braga, Stefania Sella, Maria Teresa Vilei, Giuseppe Feltrin, Antonio Gambino, Ilenia Pepe, Maurizio Rossini, Silvano Adami et al. · 2011 · Transplantation
Body composition and vertebral fracture risk in female patients treated with glucocorticoid
Hiroshi Kaji, Takako Tobimatsu, J. Naito, Mei-Fway Iu, Mika Yamauchi, Toshitsugu Sugimoto, Kazuo Chihara · 2005 · Osteoporosis International
The risk of osteoporosis in oral steroid treatment for nasal polyposis: a systematic review
L. Winblad, C.G. Larsen, Katrin Håkansson, Bo Abrahamsen, Christian von Buchwald · 2017 · Rhinology Journal
Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long‐term and low‐dose glucocorticoid
Kyung‐Ann Lee, Jong‐Sun Kim, Hyun‐Joo Kim, Hyun‐Sook Kim · 2021 · International Journal of Rheumatic Diseases
Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture
Donald B. Kimmel, S. Vennin, Anastasia S. Desyatova, Joseph A. Turner, M. P. Akhter, Joan M. Lappe, Robert R. Recker · 2022 · Osteoporosis International
Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
So Young Park, Hyun Sik Gong, Kyoung Min Kim, Dam Kim, Ha Young Kim, Chan Hong Jeon, Ji Hyeon Ju, Shin‐Seok Lee, Dong Ah Park, Yoon‐Kyoung Sung et al. · 2018 · Journal of Rheumatic Diseases
Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk
Eustathios I. Kenanidis, Michael E. Potoupnis, Panagiotis Kakoulidis, Andreas O. Leonidou, Grigorios Theocharis Sakellariou, Fares E. Sayegh, Eleftherios E. Tsiridis · 2015 · Expert Opinion on Drug Safety
Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats
Yūkō Fujita, Koji Watanabe, Shinsaku Uchikanbori, Kenshi Maki · 2011 · American Journal of Orthodontics and Dentofacial Orthopedics
Effects of Alfacalcidol on Mechanical Properties and Collagen Cross-Links of the Femoral Diaphysis in Glucocorticoid-Treated Rats
Mitsuru Saito, Keishi Marumo, Chikara Ushiku, Soki Kato, Sadaoki Sakai, Naohiko Hayakawa, Masahiko Mihara, Ayako Shiraishi · 2011 · Calcified Tissue International
3 Tesla MRI detects deterioration in proximal femur microarchitecture and strength in long‐term glucocorticoid users compared with controls
Gregory A. Chang, Chamith S. Rajapakse, Ravinder Reddy Regatte, James S. Babb, Amit Saxena, Michael H Belmont, Stephen Honig · 2015 · Journal of Magnetic Resonance Imaging
Bone Mineral Density and Body Composition in Men With Multiple Sclerosis Chronically Treated With Low-Dose Glucocorticoids
Vı́t Zikán, Michaela Týblová, Ivan Raška, Eva Havrdová, Maria Luchavova, Dana Michalská, Aleš Antonín Kuběna · 2012 · Physiological Research
Metabolic Bone Disease
Joseph A. Lorenzo, ERNESTO M. CANALIS, Lawrence G. Raisz · 2011 · Elsevier eBooks
The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: A cohort study
Danielle E Robinson, Tjeerd Pieter van Staa, Elaine Margaret Dennison, Cyrus C. Cooper, William Gregory Dixon · 2018 · Bone
Fracture risk in systemic lupus erythematosus patients over 28 years
Daniela Garelick, Sara Moreira Pinto, Filipa Farinha, Tatiana Costa Pires, Emon Khan, David Alan Isenberg · 2020 · Rheumatology
Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
Timothy Beukelman, Kenneth G. Saag, Jeffrey R. Curtis, Meredith L. Kilgore, Maria Pisu · 2009 · Osteoporosis International
Glucocorticoid Attenuates the Anabolic Effects of Parathyroid Hormone on Fracture Repair
Anthony R. Doyon, Ian K. Ferries, Jiliang Li · 2010 · Calcified Tissue International
Prednisolone treatment reduces the osteogenic effects of loading in mice
Ingrid B. Bergström, Hanna Isaksson, Antti Koskela, Juha Tuukkanen, Claes Ohlsson, Göran N. Andersson, Sara H. Windahl · 2018 · Bone
Evaluation des Trabecular Bone Score (TBS) in der täglichen Praxis bei Patienten mit entzündlich rheumatischen und nichtentzündlichen Erkrankungen
Bjoern Buehring, Jan Peter Thomas, T. Wittkämper, Xenofon Baraliakos, Jürgen Braun · 2020 · Zeitschrift für Rheumatologie
The skeletal consequences of epidural steroid injections: a literature review
Alexandra N. Krez, Yonggang Liu, Sarah Kanbour, Shannon Clare, Seth A. Waldman, E.M. Stein · 2021 · Osteoporosis International
Challenges in the diagnosis and management of glucocorticoid‐induced osteoporosis in younger and older adults
Madhuni Herath, Bente Lomholt Langdahl, Peter Robert Ebeling, Frances Milat · 2021 · Clinical Endocrinology
A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology
Simpson Bobo Tanner, Moore · 2012 · Open Access Rheumatology Research and Reviews
Prevention of glucocorticoid-induced osteoporosis
MS van Brussel, Irene E. M. Bultink, Willem Frederik Lems · 2009 · Expert Opinion on Pharmacotherapy
Skeletal Effects of Systemic and Topical Corticosteroids
Peter Vestergaard · 2008 · Current Drug Safety
Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone
Manuel Sosa Henríquez, Esteban Jódar, Pedro Saavedra, María del Carmen Navarro, Marı́a Jesús Gómez de Tejada, A. Martín, P. Peña, José-Manuel Quesada Gómez · 2007 · European Journal of Internal Medicine
Skeletal assessment with finite element analysis: relevance, pitfalls and interpretation
Graeme Michael Campbell, Claus‐C. Glüer · 2017 · Current Opinion in Rheumatology
Osteopenia: A Diagnostic and Therapeutic Challenge
Willem Frederik Lems, Hennie G. Raterman, Joop P. van den Bergh, Hans W. J. Bijlsma, Niek K. Valk, M. Carola Zillikens, Piet Geusens · 2011 · Current Osteoporosis Reports
Glucocorticoid Excess Affects Cortical Bone Geometry in Premenopausal, but not Postmenopausal, Women
Hiroshi Kaji, Mika Yamauchi, Kazuo Chihara, Toshitsugu Sugimoto · 2008 · Calcified Tissue International
Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease
Olorunfemi A. Oshagbemi, Andrea Michelle Burden, Kimberly N. Shudofsky, Johanna H. M. Driessen, Peter Vestergaard, Andreas Krings, Frits M.E. Franssen, Joop P. van den Bergh, Frank de Vries · 2018 · Bone
Lower Spine Volumetric Bone Density in Patients With a History of Epidural Steroid Injections
Yi Liu, John A. Carrino, Alexander S. Dash, Tariq Chukir, Huong T. Do, Richard S. Bockman, Alexander P. Hughes, Joel M. Press, Emily Margaret Stein · 2018 · The Journal of Clinical Endocrinology & Metabolism
The Renin–Angiotensin System and Bone
Juan Luis Tamargo, Ricardo Caballero, Eva Delpón · 2015 · Clinical Reviews in Bone and Mineral Metabolism
The conundrum of glucocorticoid-induced osteoporosis
Steven L. Teitelbaum · 2012 · Nature Reviews Endocrinology
Bone densitometry and bone biopsy
Stuart H. Ralston · 2005 · Best Practice & Research Clinical Rheumatology
Icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice.
Jing Zhang, Jia Song, Jiang Shao · 2015 · Europe PMC (PubMed Central)
Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women According to Antiosteoporotic Medication Use
Jeong Hun Suh · 2016 · Pain Physician
Effects of Epidural Steroid Injections on Bone Mineral Density and Bone Turnover Markers in Patients Taking Anti-Osteoporotic Medications
Jae Hyup Lee · 2018 · Pain Physician